Aristeia Capital’s Highland Transcend Partners I Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 HTPA.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-534,483
Closed -$588K 578
2021
Q2
$588K Buy
534,483
+33,333
+7% +$32.4K 0.01% 381
2021
Q1
$626K Buy
+501,150
New +$856K 0.01% 380

Other funds holding HTPA.WS

Aristeia Capital's HTPA.WS Position: Q3 2021 in Review

Aristeia Capital sold out of Highland Transcend Partners I Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 (HTPA.WS) in Q3 2021, closing a stake of 534,483 shares — an estimated $588K sold.

Aristeia Capital first reported a position in HTPA.WS in Q1 2021 and held it in 2 quarters. The position peaked at $626K in Q1 2021. 37 funds tracked by Wall St. Rank hold HTPA.WS as of Q3 2021.

  • Aristeia Capital reported no remaining Highland Transcend Partners I Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position as of Q3 2021 after selling out during the quarter.
  • Aristeia Capital sold 534,483 Highland Transcend Partners I Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 shares in Q3 2021, an estimated $588K.
  • Aristeia Capital first reported a position in Highland Transcend Partners I Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 in Q1 2021 and held it in 2 quarters.
  • Aristeia Capital's Highland Transcend Partners I Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position peaked at $626K in Q1 2021.
  • 37 funds tracked by Wall St. Rank held Highland Transcend Partners I Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 as of Q3 2021.

Based on Aristeia Capital's 13F filing for Q3 2021, filed 15 Nov 2021.